These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

421 related items for PubMed ID: 17280756

  • 1. Immunogenicity of a subunit vaccine against Bacillus anthracis.
    Chichester JA, Musiychuk K, de la Rosa P, Horsey A, Stevenson N, Ugulava N, Rabindran S, Palmer GA, Mett V, Yusibov V.
    Vaccine; 2007 Apr 20; 25(16):3111-4. PubMed ID: 17280756
    [Abstract] [Full Text] [Related]

  • 2. A plant based protective antigen [PA(dIV)] vaccine expressed in chloroplasts demonstrates protective immunity in mice against anthrax.
    Gorantala J, Grover S, Goel D, Rahi A, Jayadev Magani SK, Chandra S, Bhatnagar R.
    Vaccine; 2011 Jun 15; 29(27):4521-33. PubMed ID: 21504775
    [Abstract] [Full Text] [Related]

  • 3. A synthetic peptide vaccine directed against the 2ß2-2ß3 loop of domain 2 of protective antigen protects rabbits from inhalation anthrax.
    Oscherwitz J, Yu F, Cease KB.
    J Immunol; 2010 Sep 15; 185(6):3661-8. PubMed ID: 20696862
    [Abstract] [Full Text] [Related]

  • 4. Protective activity and immunogenicity of two recombinant anthrax vaccines for veterinary use.
    Fasanella A, Tonello F, Garofolo G, Muraro L, Carattoli A, Adone R, Montecucco C.
    Vaccine; 2008 Oct 23; 26(45):5684-8. PubMed ID: 18775462
    [Abstract] [Full Text] [Related]

  • 5. Efficacious, nontoxigenic Bacillus anthracis spore vaccines based on strains expressing mutant variants of lethal toxin components.
    Mendelson I, Gat O, Aloni-Grinstein R, Altboum Z, Inbar I, Kronman C, Bar-Haim E, Cohen S, Velan B, Shafferman A.
    Vaccine; 2005 Dec 01; 23(48-49):5688-97. PubMed ID: 16039760
    [Abstract] [Full Text] [Related]

  • 6. [Immunogenicity of the recombinant Bacillus strains with cloned gene of biosynthesis of protective antigen against Bacillus anthracis].
    Mikshis NI, Kudriavtseva OM, Bolothikova MF, Shulepov DV, Novikova LV, Popov IuA, Shchukovskaia TN, Drozdov IG, Kutyrev VV.
    Mol Gen Mikrobiol Virusol; 2007 Dec 01; (3):15-21. PubMed ID: 17886469
    [Abstract] [Full Text] [Related]

  • 7. An intranasal vaccine targeting both the Bacillus anthracis toxin and bacterium provides protection against aerosol spore challenge in rabbits.
    Wimer-Mackin S, Hinchcliffe M, Petrie CR, Warwood SJ, Tino WT, Williams MS, Stenz JP, Cheff A, Richardson C.
    Vaccine; 2006 May 01; 24(18):3953-63. PubMed ID: 16530302
    [Abstract] [Full Text] [Related]

  • 8. Plasmid-based vaccination with candidate anthrax vaccine antigens induces durable type 1 and type 2 T-helper immune responses.
    Zhang Y, Qiu J, Zhou Y, Farhangfar F, Hester J, Lin AY, Decker WK.
    Vaccine; 2008 Jan 30; 26(5):614-22. PubMed ID: 18166249
    [Abstract] [Full Text] [Related]

  • 9. Immunogenicity and efficacy of an anthrax/plague DNA fusion vaccine in a mouse model.
    Albrecht MT, Eyles JE, Baillie LW, Keane-Myers AM.
    FEMS Immunol Med Microbiol; 2012 Aug 30; 65(3):505-9. PubMed ID: 22515653
    [Abstract] [Full Text] [Related]

  • 10. Oral administration of a Salmonella enterica-based vaccine expressing Bacillus anthracis protective antigen confers protection against aerosolized B. anthracis.
    Stokes MG, Titball RW, Neeson BN, Galen JE, Walker NJ, Stagg AJ, Jenner DC, Thwaite JE, Nataro JP, Baillie LW, Atkins HS.
    Infect Immun; 2007 Apr 30; 75(4):1827-34. PubMed ID: 17145938
    [Abstract] [Full Text] [Related]

  • 11. A plant-produced protective antigen vaccine confers protection in rabbits against a lethal aerosolized challenge with Bacillus anthracis Ames spores.
    Chichester JA, Manceva SD, Rhee A, Coffin MV, Musiychuk K, Mett V, Shamloul M, Norikane J, Streatfield SJ, Yusibov V.
    Hum Vaccin Immunother; 2013 Mar 30; 9(3):544-52. PubMed ID: 23324615
    [Abstract] [Full Text] [Related]

  • 12. Poly-gamma-d-glutamic acid and protective antigen conjugate vaccines induce functional antibodies against the protective antigen and capsule of Bacillus anthracis in guinea-pigs and rabbits.
    Lee DY, Chun JH, Ha HJ, Park J, Kim BS, Oh HB, Rhie GE.
    FEMS Immunol Med Microbiol; 2009 Nov 30; 57(2):165-72. PubMed ID: 19732139
    [Abstract] [Full Text] [Related]

  • 13. Mouse model characterisation for anthrax vaccine development: comparison of one inbred and one outbred mouse strain.
    Flick-Smith HC, Waters EL, Walker NJ, Miller J, Stagg AJ, Green M, Williamson ED.
    Microb Pathog; 2005 Jan 30; 38(1):33-40. PubMed ID: 15652293
    [Abstract] [Full Text] [Related]

  • 14. Anthrax capsule vaccine protects against experimental infection.
    Chabot DJ, Scorpio A, Tobery SA, Little SF, Norris SL, Friedlander AM.
    Vaccine; 2004 Nov 15; 23(1):43-7. PubMed ID: 15519706
    [Abstract] [Full Text] [Related]

  • 15. Comparability of ELISA and toxin neutralization to measure immunogenicity of Protective Antigen in mice, as part of a potency test for anthrax vaccines.
    Parreiras PM, Sirota LA, Wagner LD, Menzies SL, Arciniega JL.
    Vaccine; 2009 Jul 16; 27(33):4537-42. PubMed ID: 19501205
    [Abstract] [Full Text] [Related]

  • 16. Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge.
    Bielinska AU, Janczak KW, Landers JJ, Makidon P, Sower LE, Peterson JW, Baker JR.
    Infect Immun; 2007 Aug 16; 75(8):4020-9. PubMed ID: 17502384
    [Abstract] [Full Text] [Related]

  • 17. Generation of protective immune response against anthrax by oral immunization with protective antigen plant-based vaccine.
    Gorantala J, Grover S, Rahi A, Chaudhary P, Rajwanshi R, Sarin NB, Bhatnagar R.
    J Biotechnol; 2014 Apr 20; 176():1-10. PubMed ID: 24548460
    [Abstract] [Full Text] [Related]

  • 18. Production of Functionally Active and Immunogenic Non-Glycosylated Protective Antigen from Bacillus anthracis in Nicotiana benthamiana by Co-Expression with Peptide-N-Glycosidase F (PNGase F) of Flavobacterium meningosepticum.
    Mamedov T, Chichester JA, Jones RM, Ghosh A, Coffin MV, Herschbach K, Prokhnevsky AI, Streatfield SJ, Yusibov V.
    PLoS One; 2016 Apr 20; 11(4):e0153956. PubMed ID: 27101370
    [Abstract] [Full Text] [Related]

  • 19. Comparative vaccine efficacy of different isoforms of recombinant protective antigen against Bacillus anthracis spore challenge in rabbits.
    Ribot WJ, Powell BS, Ivins BE, Little SF, Johnson WM, Hoover TA, Norris SL, Adamovicz JJ, Friedlander AM, Andrews GP.
    Vaccine; 2006 Apr 24; 24(17):3469-76. PubMed ID: 16519970
    [Abstract] [Full Text] [Related]

  • 20. Potentiation of an anthrax DNA vaccine with electroporation.
    Luxembourg A, Hannaman D, Nolan E, Ellefsen B, Nakamura G, Chau L, Tellez O, Little S, Bernard R.
    Vaccine; 2008 Sep 19; 26(40):5216-22. PubMed ID: 18462850
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.